If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,127.00    0.50 (0.04%)
Bid:
1,125.50
Ask:
1,126.50
Spread: 1.00 (0.089%)
Market Cap: £9.52b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

9 Dec 2022 11:30

RNS Number : 2420J
Smith & Nephew Plc
09 December 2022
 

SMITH & NEPHEW PLC

 

9 December 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 8 December 2022, the following award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under an award agreement to Deepak Nath. 

 

VESTING OF A PERFORMANCE AWARD GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022

 

As set out in the announcement published on 3 May 2022, a Performance Award over 127,461 shares was granted to Deepak Nath with an expected vest date of 9 November 2022. The vest of this award was subject to the performance conditions applicable to the performance stock award over Siemens Healthineers AG ("SH") shares originally granted to Deepak Nath by SH on 9 November 2018.

 

In accordance with the terms of the award agreement, the expected vest date of 9 November 2022 was delayed so that the applicable performance criteria attaching to the Performance Award could be measured against the financial results of SH which were announced on 23 November 2022. It has been determined that, following completion of the performance measurement period, 91.985% of the award vests. 117,245 shares were therefore available for vest with the remaining balance of shares, 10,216, lapsing with immediate effect.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Final vest of a Performance Award granted on 29 April 2022 under the award agreement.

Date of Transaction

2022 - 12 - 08

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Deepak Nath

(Chief Executive Officer)

Director

10.96

117,245 (of which 28,650 were sold to cover taxes due and 88,595 retained)

N/A Single Transaction

97,784.00000 ordinary shares

0.01114%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLLFTLAIIF
Date   Source Headline
24th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20204:38 pmRNSPrice Monitoring Extension
10th Mar 20205:32 pmRNSDirector/PDMR Shareholding
9th Mar 20205:06 pmRNSDirector/PDMR Shareholding
5th Mar 202012:55 pmRNSHolding(s) in Company
5th Mar 20207:01 amRNSDirectorate Change
5th Mar 20207:00 amRNSDirectorate Change
2nd Mar 20205:00 pmRNSAnnual Financial Report
2nd Mar 20203:46 pmRNSTransaction in Own Shares
2nd Mar 20201:46 pmRNSTotal Voting Rights
25th Feb 20206:20 pmRNSTransaction in Own Shares
24th Feb 20205:52 pmRNSTransaction in Own Shares
24th Feb 202011:12 amRNSDirector/PDMR Shareholding
21st Feb 20204:11 pmRNSDirector/PDMR Shareholding
21st Feb 202010:48 amRNSTransaction in Own Shares
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
7th Feb 20203:10 pmRNSDirector/PDMR Shareholding
6th Feb 20208:24 amRNSDirector Declaration
3rd Feb 20202:25 pmRNSBlock listing Interim Review
3rd Feb 202011:24 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSSmith+Nephew acquires Tusker Medical, Inc.
21st Jan 20203:00 pmRNSNotice of Results
16th Jan 20203:56 pmRNSDirector/PDMR Shareholding
2nd Jan 202010:34 amRNSTotal Voting Rights
2nd Dec 20194:34 pmRNSAdditional Listing
2nd Dec 201912:13 pmRNSTotal Voting Rights
20th Nov 20199:17 amRNSDirector/PDMR Shareholding
14th Nov 20199:17 amRNSDirector/PDMR Shareholding
12th Nov 20194:21 pmRNSTransaction in Own Shares
8th Nov 201912:54 pmRNSTransaction in Own Shares
8th Nov 20199:07 amRNSDirector/PDMR Shareholding
7th Nov 20195:33 pmRNSTransaction in Own Shares
6th Nov 20195:56 pmRNSTransaction in Own Shares
6th Nov 20193:05 pmRNSDirector/PDMR Shareholding
5th Nov 20196:13 pmRNSTransaction in Own Shares
4th Nov 20191:07 pmRNSDirector Declaration
4th Nov 201911:50 amRNSTransaction in Own Shares
1st Nov 20191:24 pmRNSDirector/PDMR Shareholding
1st Nov 201910:53 amRNSTotal Voting Rights
31st Oct 20194:43 pmRNSDirector/PDMR Shareholding
31st Oct 201911:21 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSTrading Statement
21st Oct 20197:00 amRNSDirectorate Change
18th Oct 20199:17 amRNSDividend Declaration
15th Oct 20191:14 pmRNSNotification of Major Holdings in Company
14th Oct 20198:56 amRNSNotification of Major Holdings in Company
3rd Oct 201911:15 amRNSNotification of Major Holdings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.